Global Alzheimer’s Disease Diagnostic Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 207047
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Alzheimer’s Disease Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Alzheimer’s Disease Diagnostic size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Alzheimer’s Disease Diagnostic market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Alzheimer’s Disease Diagnostic market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Nervous System Examination

Genetic Testing

Minor Mental State Examination (Mmse)

Brain Imaging

Market segment by Application, can be divided into

Early-Onset Alzheimer's Disease

Familial Alzheimer's Disease

Late-Onset Alzheimer's Disease

Market segment by players, this report covers

Eli Lilly and Company

Novartis

Merck

F. Hoffmann-La Roche

Pfizer

TauRx

Alector

Accera

Treventis Corporation

Neuro-Bio

Cognition Therapeutics

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Alzheimer’s Disease Diagnostic

1.2 Classification of Alzheimer’s Disease Diagnostic by Type

1.2.1 Overview: Global Alzheimer’s Disease Diagnostic Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type in 2020

1.2.3 Nervous System Examination

1.2.4 Genetic Testing

1.2.5 Minor Mental State Examination (Mmse)

1.2.6 Brain Imaging

1.3 Global Alzheimer’s Disease Diagnostic Market by Application

1.3.1 Overview: Global Alzheimer’s Disease Diagnostic Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Early-Onset Alzheimer's Disease

1.3.3 Familial Alzheimer's Disease

1.3.4 Late-Onset Alzheimer's Disease

1.4 Global Alzheimer’s Disease Diagnostic Market Size & Forecast

1.5 Global Alzheimer’s Disease Diagnostic Market Size and Forecast by Region

1.5.1 Global Alzheimer’s Disease Diagnostic Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Alzheimer’s Disease Diagnostic Market Size by Region, (2016-2021)

1.5.3 North America Alzheimer’s Disease Diagnostic Market Size and Prospect (2016-2026)

1.5.4 Europe Alzheimer’s Disease Diagnostic Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size and Prospect (2016-2026)

1.5.6 South America Alzheimer’s Disease Diagnostic Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Alzheimer’s Disease Diagnostic Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Alzheimer’s Disease Diagnostic Market Drivers

1.6.2 Alzheimer’s Disease Diagnostic Market Restraints

1.6.3 Alzheimer’s Disease Diagnostic Trends Analysis

2 Company Profiles

2.1 Eli Lilly and Company

2.1.1 Eli Lilly and Company Details

2.1.2 Eli Lilly and Company Major Business

2.1.3 Eli Lilly and Company Alzheimer’s Disease Diagnostic Product and Solutions

2.1.4 Eli Lilly and Company Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Eli Lilly and Company Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis Alzheimer’s Disease Diagnostic Product and Solutions

2.2.4 Novartis Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Novartis Recent Developments and Future Plans

2.3 Merck

2.3.1 Merck Details

2.3.2 Merck Major Business

2.3.3 Merck Alzheimer’s Disease Diagnostic Product and Solutions

2.3.4 Merck Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Merck Recent Developments and Future Plans

2.4 F. Hoffmann-La Roche

2.4.1 F. Hoffmann-La Roche Details

2.4.2 F. Hoffmann-La Roche Major Business

2.4.3 F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Product and Solutions

2.4.4 F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 F. Hoffmann-La Roche Recent Developments and Future Plans

2.5 Pfizer

2.5.1 Pfizer Details

2.5.2 Pfizer Major Business

2.5.3 Pfizer Alzheimer’s Disease Diagnostic Product and Solutions

2.5.4 Pfizer Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Pfizer Recent Developments and Future Plans

2.6 TauRx

2.6.1 TauRx Details

2.6.2 TauRx Major Business

2.6.3 TauRx Alzheimer’s Disease Diagnostic Product and Solutions

2.6.4 TauRx Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 TauRx Recent Developments and Future Plans

2.7 Alector

2.7.1 Alector Details

2.7.2 Alector Major Business

2.7.3 Alector Alzheimer’s Disease Diagnostic Product and Solutions

2.7.4 Alector Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Alector Recent Developments and Future Plans

2.8 Accera

2.8.1 Accera Details

2.8.2 Accera Major Business

2.8.3 Accera Alzheimer’s Disease Diagnostic Product and Solutions

2.8.4 Accera Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Accera Recent Developments and Future Plans

2.9 Treventis Corporation

2.9.1 Treventis Corporation Details

2.9.2 Treventis Corporation Major Business

2.9.3 Treventis Corporation Alzheimer’s Disease Diagnostic Product and Solutions

2.9.4 Treventis Corporation Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Treventis Corporation Recent Developments and Future Plans

2.10 Neuro-Bio

2.10.1 Neuro-Bio Details

2.10.2 Neuro-Bio Major Business

2.10.3 Neuro-Bio Alzheimer’s Disease Diagnostic Product and Solutions

2.10.4 Neuro-Bio Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Neuro-Bio Recent Developments and Future Plans

2.11 Cognition Therapeutics

2.11.1 Cognition Therapeutics Details

2.11.2 Cognition Therapeutics Major Business

2.11.3 Cognition Therapeutics Alzheimer’s Disease Diagnostic Product and Solutions

2.11.4 Cognition Therapeutics Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Cognition Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Alzheimer’s Disease Diagnostic Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Alzheimer’s Disease Diagnostic Players Market Share

3.2.2 Top 10 Alzheimer’s Disease Diagnostic Players Market Share

3.2.3 Market Competition Trend

3.3 Alzheimer’s Disease Diagnostic Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Alzheimer’s Disease Diagnostic Revenue and Market Share by Type (2016-2021)

4.2 Global Alzheimer’s Disease Diagnostic Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Application (2016-2021)

5.2 Alzheimer’s Disease Diagnostic Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Alzheimer’s Disease Diagnostic Revenue by Type (2016-2026)

6.2 North America Alzheimer’s Disease Diagnostic Revenue by Application (2016-2026)

6.3 North America Alzheimer’s Disease Diagnostic Market Size by Country

6.3.1 North America Alzheimer’s Disease Diagnostic Revenue by Country (2016-2026)

6.3.2 United States Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

6.3.3 Canada Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

6.3.4 Mexico Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Alzheimer’s Disease Diagnostic Revenue by Type (2016-2026)

7.2 Europe Alzheimer’s Disease Diagnostic Revenue by Application (2016-2026)

7.3 Europe Alzheimer’s Disease Diagnostic Market Size by Country

7.3.1 Europe Alzheimer’s Disease Diagnostic Revenue by Country (2016-2026)

7.3.2 Germany Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

7.3.3 France Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

7.3.5 Russia Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

7.3.6 Italy Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Alzheimer’s Disease Diagnostic Revenue by Type (2016-2026)

8.2 Asia-Pacific Alzheimer’s Disease Diagnostic Revenue by Application (2016-2026)

8.3 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region

8.3.1 Asia-Pacific Alzheimer’s Disease Diagnostic Revenue by Region (2016-2026)

8.3.2 China Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

8.3.3 Japan Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

8.3.4 South Korea Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

8.3.5 India Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

8.3.7 Australia Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Alzheimer’s Disease Diagnostic Revenue by Type (2016-2026)

9.2 South America Alzheimer’s Disease Diagnostic Revenue by Application (2016-2026)

9.3 South America Alzheimer’s Disease Diagnostic Market Size by Country

9.3.1 South America Alzheimer’s Disease Diagnostic Revenue by Country (2016-2026)

9.3.2 Brazil Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

9.3.3 Argentina Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Alzheimer’s Disease Diagnostic Revenue by Type (2016-2026)

10.2 Middle East & Africa Alzheimer’s Disease Diagnostic Revenue by Application (2016-2026)

10.3 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country

10.3.1 Middle East & Africa Alzheimer’s Disease Diagnostic Revenue by Country (2016-2026)

10.3.2 Turkey Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

10.3.4 UAE Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Alzheimer’s Disease Diagnostic Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Alzheimer’s Disease Diagnostic Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Alzheimer’s Disease Diagnostic Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Alzheimer’s Disease Diagnostic Revenue (USD Million) by Region (2016-2021)

Table 5. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Region (2021-2026)

Table 6. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors

Table 7. Eli Lilly and Company Major Business

Table 8. Eli Lilly and Company Alzheimer’s Disease Diagnostic Product and Solutions

Table 9. Eli Lilly and Company Alzheimer’s Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Novartis Corporate Information, Head Office, and Major Competitors

Table 11. Novartis Major Business

Table 12. Novartis Alzheimer’s Disease Diagnostic Product and Solutions

Table 13. Novartis Alzheimer’s Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Merck Corporate Information, Head Office, and Major Competitors

Table 15. Merck Major Business

Table 16. Merck Alzheimer’s Disease Diagnostic Product and Solutions

Table 17. Merck Alzheimer’s Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors

Table 19. F. Hoffmann-La Roche Major Business

Table 20. F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Product and Solutions

Table 21. F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Pfizer Corporate Information, Head Office, and Major Competitors

Table 23. Pfizer Major Business

Table 24. Pfizer Alzheimer’s Disease Diagnostic Product and Solutions

Table 25. Pfizer Alzheimer’s Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. TauRx Corporate Information, Head Office, and Major Competitors

Table 27. TauRx Major Business

Table 28. TauRx Alzheimer’s Disease Diagnostic Product and Solutions

Table 29. TauRx Alzheimer’s Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Alector Corporate Information, Head Office, and Major Competitors

Table 31. Alector Major Business

Table 32. Alector Alzheimer’s Disease Diagnostic Product and Solutions

Table 33. Alector Alzheimer’s Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Accera Corporate Information, Head Office, and Major Competitors

Table 35. Accera Major Business

Table 36. Accera Alzheimer’s Disease Diagnostic Product and Solutions

Table 37. Accera Alzheimer’s Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Treventis Corporation Corporate Information, Head Office, and Major Competitors

Table 39. Treventis Corporation Major Business

Table 40. Treventis Corporation Alzheimer’s Disease Diagnostic Product and Solutions

Table 41. Treventis Corporation Alzheimer’s Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Neuro-Bio Corporate Information, Head Office, and Major Competitors

Table 43. Neuro-Bio Major Business

Table 44. Neuro-Bio Alzheimer’s Disease Diagnostic Product and Solutions

Table 45. Neuro-Bio Alzheimer’s Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Cognition Therapeutics Corporate Information, Head Office, and Major Competitors

Table 47. Cognition Therapeutics Major Business

Table 48. Cognition Therapeutics Alzheimer’s Disease Diagnostic Product and Solutions

Table 49. Cognition Therapeutics Alzheimer’s Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Global Alzheimer’s Disease Diagnostic Revenue (USD Million) by Players (2019-2021)

Table 51. Global Alzheimer’s Disease Diagnostic Revenue Share by Players (2019-2021)

Table 52. Breakdown of Alzheimer’s Disease Diagnostic by Company Type (Tier 1, Tier 2 and Tier 3)

Table 53. Alzheimer’s Disease Diagnostic Players Head Office, Products and Services Provided

Table 54. Alzheimer’s Disease Diagnostic Mergers & Acquisitions in the Past Five Years

Table 55. Alzheimer’s Disease Diagnostic New Entrants and Expansion Plans

Table 56. Global Alzheimer’s Disease Diagnostic Revenue (USD Million) by Type (2016-2021)

Table 57. Global Alzheimer’s Disease Diagnostic Revenue Share by Type (2016-2021)

Table 58. Global Alzheimer’s Disease Diagnostic Revenue Forecast by Type (2021-2026)

Table 59. Global Alzheimer’s Disease Diagnostic Revenue by Application (2016-2021)

Table 60. Global Alzheimer’s Disease Diagnostic Revenue Forecast by Application (2021-2026)

Table 61. North America Alzheimer’s Disease Diagnostic Revenue by Type (2016-2021) & (USD Million)

Table 62. North America Alzheimer’s Disease Diagnostic Revenue by Type (2021-2026) & (USD Million)

Table 63. North America Alzheimer’s Disease Diagnostic Revenue by Application (2016-2021) & (USD Million)

Table 64. North America Alzheimer’s Disease Diagnostic Revenue by Application (2021-2026) & (USD Million)

Table 65. North America Alzheimer’s Disease Diagnostic Revenue by Country (2016-2021) & (USD Million)

Table 66. North America Alzheimer’s Disease Diagnostic Revenue by Country (2021-2026) & (USD Million)

Table 67. Europe Alzheimer’s Disease Diagnostic Revenue by Type (2016-2021) & (USD Million)

Table 68. Europe Alzheimer’s Disease Diagnostic Revenue by Type (2021-2026) & (USD Million)

Table 69. Europe Alzheimer’s Disease Diagnostic Revenue by Application (2016-2021) & (USD Million)

Table 70. Europe Alzheimer’s Disease Diagnostic Revenue by Application (2021-2026) & (USD Million)

Table 71. Europe Alzheimer’s Disease Diagnostic Revenue by Country (2016-2021) & (USD Million)

Table 72. Europe Alzheimer’s Disease Diagnostic Revenue by Country (2021-2026) & (USD Million)

Table 73. Asia-Pacific Alzheimer’s Disease Diagnostic Revenue by Type (2016-2021) & (USD Million)

Table 74. Asia-Pacific Alzheimer’s Disease Diagnostic Revenue by Type (2021-2026) & (USD Million)

Table 75. Asia-Pacific Alzheimer’s Disease Diagnostic Revenue by Application (2016-2021) & (USD Million)

Table 76. Asia-Pacific Alzheimer’s Disease Diagnostic Revenue by Application (2021-2026) & (USD Million)

Table 77. Asia-Pacific Alzheimer’s Disease Diagnostic Revenue by Region (2016-2021) & (USD Million)

Table 78. Asia-Pacific Alzheimer’s Disease Diagnostic Revenue by Region (2021-2026) & (USD Million)

Table 79. South America Alzheimer’s Disease Diagnostic Revenue by Type (2016-2021) & (USD Million)

Table 80. South America Alzheimer’s Disease Diagnostic Revenue by Type (2021-2026) & (USD Million)

Table 81. South America Alzheimer’s Disease Diagnostic Revenue by Application (2016-2021) & (USD Million)

Table 82. South America Alzheimer’s Disease Diagnostic Revenue by Application (2021-2026) & (USD Million)

Table 83. South America Alzheimer’s Disease Diagnostic Revenue by Country (2016-2021) & (USD Million)

Table 84. South America Alzheimer’s Disease Diagnostic Revenue by Country (2021-2026) & (USD Million)

Table 85. Middle East & Africa Alzheimer’s Disease Diagnostic Revenue by Type (2016-2021) & (USD Million)

Table 86. Middle East & Africa Alzheimer’s Disease Diagnostic Revenue by Type (2021-2026) & (USD Million)

Table 87. Middle East & Africa Alzheimer’s Disease Diagnostic Revenue by Application (2016-2021) & (USD Million)

Table 88. Middle East & Africa Alzheimer’s Disease Diagnostic Revenue by Application (2021-2026) & (USD Million)

Table 89. Middle East & Africa Alzheimer’s Disease Diagnostic Revenue by Country (2016-2021) & (USD Million)

Table 90. Middle East & Africa Alzheimer’s Disease Diagnostic Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Alzheimer’s Disease Diagnostic Picture

Figure 2. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type in 2020

Figure 3. Nervous System Examination

Figure 4. Genetic Testing

Figure 5. Minor Mental State Examination (Mmse)

Figure 6. Brain Imaging

Figure 7. Alzheimer’s Disease Diagnostic Revenue Market Share by Application in 2020

Figure 8. Early-Onset Alzheimer's Disease Picture

Figure 9. Familial Alzheimer's Disease Picture

Figure 10. Late-Onset Alzheimer's Disease Picture

Figure 11. Global Alzheimer’s Disease Diagnostic Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 12. Global Alzheimer’s Disease Diagnostic Revenue and Forecast (2016-2026) & (USD Million)

Figure 13. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Region (2016-2026)

Figure 14. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Region in 2020

Figure 15. North America Alzheimer’s Disease Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Europe Alzheimer’s Disease Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Asia-Pacific Alzheimer’s Disease Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. South America Alzheimer’s Disease Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Middle East and Africa Alzheimer’s Disease Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Alzheimer’s Disease Diagnostic Market Drivers

Figure 21. Alzheimer’s Disease Diagnostic Market Restraints

Figure 22. Alzheimer’s Disease Diagnostic Market Trends

Figure 23. Eli Lilly and Company Recent Developments and Future Plans

Figure 24. Novartis Recent Developments and Future Plans

Figure 25. Merck Recent Developments and Future Plans

Figure 26. F. Hoffmann-La Roche Recent Developments and Future Plans

Figure 27. Pfizer Recent Developments and Future Plans

Figure 28. TauRx Recent Developments and Future Plans

Figure 29. Alector Recent Developments and Future Plans

Figure 30. Accera Recent Developments and Future Plans

Figure 31. Treventis Corporation Recent Developments and Future Plans

Figure 32. Neuro-Bio Recent Developments and Future Plans

Figure 33. Cognition Therapeutics Recent Developments and Future Plans

Figure 34. Global Alzheimer’s Disease Diagnostic Revenue Share by Players in 2020

Figure 35. Alzheimer’s Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 36. Global Top 3 Players Alzheimer’s Disease Diagnostic Revenue Market Share in 2020

Figure 37. Global Top 10 Players Alzheimer’s Disease Diagnostic Revenue Market Share in 2020

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 39. Global Alzheimer’s Disease Diagnostic Revenue Share by Type in 2020

Figure 40. Global Alzheimer’s Disease Diagnostic Market Share Forecast by Type (2021-2026)

Figure 41. Global Alzheimer’s Disease Diagnostic Revenue Share by Application in 2020

Figure 42. Global Alzheimer’s Disease Diagnostic Market Share Forecast by Application (2021-2026)

Figure 43. North America Alzheimer’s Disease Diagnostic Sales Market Share by Type (2016-2026)

Figure 44. North America Alzheimer’s Disease Diagnostic Sales Market Share by Application (2016-2026)

Figure 45. North America Alzheimer’s Disease Diagnostic Revenue Market Share by Country (2016-2026)

Figure 46. United States Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Canada Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Mexico Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Europe Alzheimer’s Disease Diagnostic Sales Market Share by Type (2016-2026)

Figure 50. Europe Alzheimer’s Disease Diagnostic Sales Market Share by Application (2016-2026)

Figure 51. Europe Alzheimer’s Disease Diagnostic Revenue Market Share by Country (2016-2026)

Figure 52. Germany Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. France Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. United Kingdom Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Russia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Italy Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Asia-Pacific Alzheimer’s Disease Diagnostic Sales Market Share by Type (2016-2026)

Figure 58. Asia-Pacific Alzheimer’s Disease Diagnostic Sales Market Share by Application (2016-2026)

Figure 59. Asia-Pacific Alzheimer’s Disease Diagnostic Revenue Market Share by Region (2016-2026)

Figure 60. China Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Japan Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South Korea Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. India Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Southeast Asia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Australia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. South America Alzheimer’s Disease Diagnostic Sales Market Share by Type (2016-2026)

Figure 67. South America Alzheimer’s Disease Diagnostic Sales Market Share by Application (2016-2026)

Figure 68. South America Alzheimer’s Disease Diagnostic Revenue Market Share by Country (2016-2026)

Figure 69. Brazil Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Argentina Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Middle East and Africa Alzheimer’s Disease Diagnostic Sales Market Share by Type (2016-2026)

Figure 72. Middle East and Africa Alzheimer’s Disease Diagnostic Sales Market Share by Application (2016-2026)

Figure 73. Middle East and Africa Alzheimer’s Disease Diagnostic Revenue Market Share by Country (2016-2026)

Figure 74. Turkey Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Saudi Arabia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. UAE Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz